Navigation Links
Magnetism and mimicry of nature hold hope for better medicine, environmental safety

the international effort by the Interdisciplinary Network of Emerging Science and Technology (INEST), directed by Manuel Marquez, an adjunct professor of bioengineering at ASU. He and Lindsay are affiliated with the INEST group research center in Richmond, Va., supported by the Philip Morris USA company.

Marquez, and fellow researchers in Spain, including professors Sonia Melle at Universidad Complutense de Madrid and Miguel Angel Rubio, and graduate student Pablo Dominquez-Garcia at Universidad Nacional de Educacion por Distancia, who have produced the first demonstration of the new technology, are an integral part of the microfluidics project.

The team's findings could have a vast impact on the field of bioanalysis, Hayes says.

The key to the method's effectiveness is using nanoscale surface patterns to create a "superhydrophobic" (or water-repellent) surface on which to collect extremely tiny droplets of fluids ?a surface formed by mimicking the natural self-cleaning process exhibited by the leaves of the Lotus plant, Hayes explains.

Water and biological fluids typically bead up like a ball on superhydrophobic surfaces, but the introduction of a magnetic field produced by injecting tiny magnetic particles into the droplets keeps the ball from rolling off the surface.

This allows for the fluids to be controlled through exerting magnetic force, and moved with extreme precision across the tips of nanowires, which are only about 200 atoms in diameter and less than a hundredth of the width of a human hair in length.

"We knew we had the perfect surface on which to analyze drops of blood and other biological fluids because the trapped air between the wires never allows for much of the fluid to come into contact with the surface," Garcia says.

That is crucial to accurate analysis because it prevents the chemicals and other materials in the droplet from combining and reacting with the chemical compounds in the
'"/>

Source:Arizona State University


Page: 1 2 3 4

Related biology news :

1. Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients
2. Bioelectronic ‘signatures?hold key to DNA mutations
3. The circadian clock: Understanding natures timepiece
4. Scientists map the world for nature conservation
5. Brain Scan Study of Smokers Reveals Signature of Craving
6. Scientists to mimic nature for newest cancer drugs
7. Researchers create functioning artificial proteins using natures rules
8. Eleven gene signature reliably predicts cancer prognosis
9. Scientists and engineers apply natures design to human problems
10. Getting close to nature is good for you
11. Phenotype is influenced by nature, nurture and noise

Post Your Comments:
(Date:11/30/2009)...port published in the December 2009 print issue of...r type of control over their fertility that women ...s have found how and where androgenic hormones wor... and male fertility. This opens a promising avenue...scovery also offers hope to those who cannot have ...
(Date:11/26/2009)... are some of the Ocean,s most distinctive resident...s strange head shape, says Michelle McComb from F... the shark,s vision. ,Perhaps their visual field h...McComb, giving the sharks excellent stereovision a... there were two schools of thought on this theory....
(Date:11/26/2009)...out in eight European countries has shown that clo... pandemic could have a significant role in reducin... open access journal BMC Infectious Diseases com...nd weekends/holidays, finding that they were reduc...elt and Antwerp University, Belgium, led a team of...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2School closure could reduce swine flu transmission by 21 percent 2New stem cell identification technology could cure breast cancer 4969 1New stem cell identification technology could cure breast cancer 4969 2First results from major European patient survey show devastating impact of living with breakthrough cancer pain 56899 1First results from major European patient survey show devastating impact of living with breakthrough cancer pain 56899 2ThromboGenics is Shortlisted for 22Biotech Company of the Year 22 and 22Licensing Deal of the Year 22 at Scrip Awards 2009 13998 1ThromboGenics is Shortlisted for 22Biotech Company of the Year 22 and 22Licensing Deal of the Year 22 at Scrip Awards 2009 13998 2ThromboGenics is Shortlisted for 22Biotech Company of the Year 22 and 22Licensing Deal of the Year 22 at Scrip Awards 2009 13998 3
...eir kind, researchers at Rice University and The U...ve determined that carbon nanotubes injected direc...ause no immediate adverse health effects and circu...d by the liver. , The findings are from the first ...on nanotubes, a revolutionary nanomaterial that ma...
...scoveries are named Charlotte, but they are weavin...studies at Texas A&M University have led to th... one species found for the first time in Texas. , ...dation, Henderson, who is earning a master,s degre...ribution and abundance in the 515-acre Lick Creek ...
... of Warwick should have gardeners and commercial g...ic waste composts. The University,s plant research... paper based composts are proving to be a major we...s. , A University of Warwick research team under ...use of composts can reduce the incidence of some i...
Other Biology News:Pure carbon nanotubes pass first in vivo test 2Ground spider diversity studied in research project 2Recycled paper and compost could both be key tools to control plant disease 2
(Date:11/30/2009)...wswire/ -- Biopharmaceutical company Kiadis,Pharma... enrolled in its,multinational registration clinic...how reduction in transplant related mortality (TRM... transplantation with a mismatched,(haplo-identica...allogeneic,stem cell transplantation but without h...
(Date:11/30/2009)...e-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasd... Administration (FDA) has granted orphan drug desi...ridine phosphate, for the rare autoimmune disease ... has previously received orphan drug designation i...or Medicinal Products for Human Use of the Europea...
(Date:11/30/2009)...swire-Asia/ -- WuXi PharmaTech (NYSE: WX ), a,le...evice research and,development outsourcing company...nnounced that it had been selected to the Deloitte...consecutive year. The list recognizes the 50,faste... and telecommunications,industries based on revenu...
(Date:11/28/2009)...l Advisory Committee on Climate Change (NACCC) thr...ct in collaboration with the Vanuatu Meteorologica...e generated preliminary climate change and sea lev...the country’s SNC reporting to the United Na...CC). , Port Vila, Vanuat...
Breaking Biology Technology:Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4
...n Investment to Finance Growth in Chindex,s Health...ina, BETHESDA, Md., Nov. 7 /Xinhua-PRNewswire/ --...ding independent American provider of Western,heal...lic of China, today,announced that it has agreed t... Management group. The investment will consist of ...
...., Nov. 7 Transgenomic Inc. (OTC,Bulletin Board: ...Transgenomic Inc. Third Quarter 2007 Earnings Rele...ay, November 7, 2007 @ 5:00 p.m. Eastern, Where: ... How: Live over the Internet -- Simply log on...tact: Investor Relations -- 402-452-5400 To acce...
... CA, Nov. 7 /PRNewswire-FirstCall/ - Nventa,Biopha...y financial results,for the third quarter ended Se...herwise, are in Canadian dollars. Nventa reported...r the,three months ended September 30, 2007, compa...are, for the same period in 2006. For the nine,mon...
Other Biology Technology:JPMorgan's Principal Investment Management Group to Invest in Chindex International, Inc. 2JPMorgan's Principal Investment Management Group to Invest in Chindex International, Inc. 3Webcast Alert: Transgenomic Inc. Announces Third Quarter 2007 Earnings Release Conference Call Webcast 2Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results 2Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results 3Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results 4
Luminex 100 Instrument System from Upstate
Goat Anti-Human HADHB Polyclonal Antibody, Unconjugated from IMGENEX
normal human fibroblasts from Exalpha Biologicals, Inc.
A431 cells from Exalpha Biologicals, Inc.
Biology Products: